Clinical trial

Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma

NCT04970251

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-11-01

PhaseNA

Study timeline

Study start (actual)2018-11-01Date precision: day

Registry last updated2021-07-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Intraocular Pressureunresolved

Neovascular Glaucomaunresolved

Vascular Endothelial Growth Factor Overexpressionunresolved

Glaucoma Secondary to Eye Inflammationunresolved

Interventions

Aflibercept OphthalmicDRUG

Sponsors & collaborators

Siriraj Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04970251 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.